Drug Shortage Report for TEVA-IRBESARTAN HCTZ

Last updated on 2020-07-15 History
Report ID 120235
Drug Identification Number 02330539
Brand name TEVA-IRBESARTAN HCTZ
Common or Proper name IRBESARTAN/HCTZ 300/25MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 25MG 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-14
Estimated end date 2020-12-31
Actual end date 2020-07-14
Shortage status Resolved
Updated date 2020-07-15
Company comments Duplicate record created in error
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-07-14 English Compare
v2 2020-07-14 French Compare
v3 2020-07-14 English Compare
v4 2020-07-14 French Compare
v5 2020-07-15 English Compare